Evidence map›Paper›PMID 41323179›Full record

ArticleRadiology case reports2026

Yttrium-90 radioembolization for treatment of anaplastic meningioma liver metastases.

Mohammad-Kasim Fassia, Arsalan Haghdel, Fred Pelzman, Rajiv Magge, Susan Pannullo, Benjamin Liechty, Theodore H Schwartz, Jonathan P S Knisely, Jana Ivanidze, Brian Currie

Abstract readCase Reports
In one paragraph

Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mohammad-Kasim FassiaDepartment of Radiology, Weill Cornell Medicine, New York, NY, USA.
Arsalan HaghdelDepartment of Radiology, Weill Cornell Medicine, New York, NY, USA.
Fred PelzmanDepartment of Medicine, Weill Cornell Medicine, New York, NY, USA.
Rajiv MaggeDepartment of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.
Susan PannulloDepartment of Neurological Surgery, Icahn School of Medicine, Mt. Sinai Hospital, New York, NY USA.
Benjamin LiechtyDepartment of Biomedical Engineering, Cornell University, Ithaca, NY.
Theodore H SchwartzDepartment of Neurological Surgery, Icahn School of Medicine, Mt. Sinai Hospital, New York, NY USA.
Jonathan P S KniselyDepartment of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.
Jana IvanidzeDepartment of Radiology, Weill Cornell Medicine, New York, NY, USA.
Brian CurrieDepartment of Diagnostic Radiology, Geisinger Health, Wilkes-Barre, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Meningiomas are the most common primary intracranial neoplasm. The WHO classification, focusing on histomorphologic and molecular features, distinguishes WHO grade -1, -2, and -3 tumors. WHO-3 meningiomas are exceedingly rare, comprising 1%-3% of cases, and have the propensity to metastasize to the lungs, followed by bone and liver. Due to their rare occurence, there are no consensus guidelines on metastatic meningioma management. External beam radiation therapy is often the treatment of choice, therefore transarterial radioembolization is a reasonable option for meningioma metastases to the liver. In this case report, we describe the clinical course and outcomes of a patient with WHO-3 meningioma and extensive hepatic metastases which were initially detected during workup for possible renal transplant, confirmed with DOTATATE PET/CT, and successfully treated with Yttrium-90 radioembolization and ablation.

Indexed as

ablationDOTATATE PET-CTMeningiomaTransarterial radioembolizationWHO III meningioma

Identifiers

PMID41323179
PMCPMC12657274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.